BioSpace News Archive

Since 2009, Catherines has raised more than $1.4M to support the ADA’s mission to prevent and cure diabetes and to improve the lives of all those affected by diabetes.

LifeOmic, the creators of the LIFE Fasting Tracker app, today announced version 2.0 of the app with new features designed to empower health and fasting coaches as well as connect app users with others in the intermittent fasting (IF) community to optimize health goals.

Lianluo Smart Limited (“Lianluo Smart” or the “Company”) (Nasdaq: LLIT), today announced its wearable sleep diagnostic products and cloud-based service from the Company’s wholly owned subsidiary, Lianluo Connection Medical Wearable Device Technology (Beijing) Co., Ltd., are now available in more than 20 medical centers of Chinese leading private preventive healthcare companies in Beijing.

U.S. News & World Report announced the 2018-19 Best Hospitals ranking, and all of the top 20 organizations utilize Hyland Healthcare solutions.

TechCare Corp. (OTCQB: TECR), a technology company with a revolutionary delivery platform that uses vapor technology for natural health, wellness and beauty treatments, today announced that it appointed Tali Dinar, former MICT Inc. executive, as its new Chief Financial Officer.

Amgen (NASDAQ:AMGN) today announced that the European Commission (EC) has approved an expanded indication for BLINCYTO® (blinatumomab) monotherapy to include adult patients with Philadelphia chromosome negative (Ph-) CD19 positive B-cell precursor acute lymphoblastic leukemia (ALL) in first or second complete remission with minimal residual disease (MRD) greater than or equal to 0.1 percent.

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced that Mr. Eyal Barad, Co-Founder and CEO, and Dr. Eyal Ballan, Co-Founder and CTO, will be in Davos, Switzerland in January, 2019. T

Indoor growing technology leader gains momentum for 2019 market expansions

The IND application was filed by I-Mab’s strategic partner TRACON Pharmaceuticals in December 2018.

Banfield Pet Hospital today unveiled its third annual Veterinary Emerging Topics (VET)® Report in partnership with the North American Veterinary Community (NAVC)